Cargando…

An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)

BACKGROUND: The management of chronic degenerative joint disorders such as osteoarthritis (OA) with ayurvedic medicines provides a safe and effective alternative. Ayurvedic medicines possess analgesic, anti-inflammatory, anti-oxidant and immunomodulator activities. AIMS: The main aim of the study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mundhe, Narendra B., Tamoli, Sanjay Motilal, Pande, Shishir Purushottam, Kulkarni, Savita Ambadas, Patil, Vishal G., Mahadik, Swapnali B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891992/
https://www.ncbi.nlm.nih.gov/pubmed/31831964
http://dx.doi.org/10.4103/ayu.AYU_8_18
_version_ 1783475940863508480
author Mundhe, Narendra B.
Tamoli, Sanjay Motilal
Pande, Shishir Purushottam
Kulkarni, Savita Ambadas
Patil, Vishal G.
Mahadik, Swapnali B.
author_facet Mundhe, Narendra B.
Tamoli, Sanjay Motilal
Pande, Shishir Purushottam
Kulkarni, Savita Ambadas
Patil, Vishal G.
Mahadik, Swapnali B.
author_sort Mundhe, Narendra B.
collection PubMed
description BACKGROUND: The management of chronic degenerative joint disorders such as osteoarthritis (OA) with ayurvedic medicines provides a safe and effective alternative. Ayurvedic medicines possess analgesic, anti-inflammatory, anti-oxidant and immunomodulator activities. AIMS: The main aim of the study was to assess the efficacy of Ayuartis capsule in patients suffering from OA of the knee(s). MATERIALS AND METHODS: Thirty-one patients suffering from OA knee(s) were recruited after evaluating them as per inclusion/exclusion criteria. Patients were advised to take two Ayuartis capsules twice daily orally for 90 days. Knee joint(s) pain was assessed on the Visual Analog Scale. Patients’ joint pain, stiffness, and physical functions were assessed on the Western Ontario McMaster University Osteoarthritis (WOMAC) index. Quality of life (QOL) and the time required to walk 50 feet was evaluated. Patients were called for follow-up visits on every 15(th) day till 90 days. Adverse events and vitals were recorded at every visit. Safety laboratory investigations were done before and after the completion of trial. STATISTICAL ANALYSIS: Data describing quantitative measures are expressed as mean ± standard deviation. The comparison of variables representing categorical data was performed using pair t-test. RESULTS: The mean joint pain reduced significantly by 53.82% on day 90. The mean WOMAC combined score, pain score, stiffness score and difficulty score reduced significantly by 50.88%, 54.96%, 58.76% and 49.02%, respectively on day 90. A significant improvement was observed in mean QOL of patients. A significant reduction in mean time required to walk 50 feet was observed. Majority of the patients had shown good overall improvement and excellent tolerability to the trial drug. CONCLUSION: Ayuartis capsule is a safe and effective medicine for the treatment of OA of the knee(s).
format Online
Article
Text
id pubmed-6891992
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-68919922019-12-12 An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s) Mundhe, Narendra B. Tamoli, Sanjay Motilal Pande, Shishir Purushottam Kulkarni, Savita Ambadas Patil, Vishal G. Mahadik, Swapnali B. Ayu Original Article BACKGROUND: The management of chronic degenerative joint disorders such as osteoarthritis (OA) with ayurvedic medicines provides a safe and effective alternative. Ayurvedic medicines possess analgesic, anti-inflammatory, anti-oxidant and immunomodulator activities. AIMS: The main aim of the study was to assess the efficacy of Ayuartis capsule in patients suffering from OA of the knee(s). MATERIALS AND METHODS: Thirty-one patients suffering from OA knee(s) were recruited after evaluating them as per inclusion/exclusion criteria. Patients were advised to take two Ayuartis capsules twice daily orally for 90 days. Knee joint(s) pain was assessed on the Visual Analog Scale. Patients’ joint pain, stiffness, and physical functions were assessed on the Western Ontario McMaster University Osteoarthritis (WOMAC) index. Quality of life (QOL) and the time required to walk 50 feet was evaluated. Patients were called for follow-up visits on every 15(th) day till 90 days. Adverse events and vitals were recorded at every visit. Safety laboratory investigations were done before and after the completion of trial. STATISTICAL ANALYSIS: Data describing quantitative measures are expressed as mean ± standard deviation. The comparison of variables representing categorical data was performed using pair t-test. RESULTS: The mean joint pain reduced significantly by 53.82% on day 90. The mean WOMAC combined score, pain score, stiffness score and difficulty score reduced significantly by 50.88%, 54.96%, 58.76% and 49.02%, respectively on day 90. A significant improvement was observed in mean QOL of patients. A significant reduction in mean time required to walk 50 feet was observed. Majority of the patients had shown good overall improvement and excellent tolerability to the trial drug. CONCLUSION: Ayuartis capsule is a safe and effective medicine for the treatment of OA of the knee(s). Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6891992/ /pubmed/31831964 http://dx.doi.org/10.4103/ayu.AYU_8_18 Text en Copyright: © 2019 AYU (An International Quarterly Journal of Research in Ayurveda) http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mundhe, Narendra B.
Tamoli, Sanjay Motilal
Pande, Shishir Purushottam
Kulkarni, Savita Ambadas
Patil, Vishal G.
Mahadik, Swapnali B.
An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
title An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
title_full An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
title_fullStr An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
title_full_unstemmed An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
title_short An open-label, prospective, multicenter, clinical study to evaluate efficacy of Ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
title_sort open-label, prospective, multicenter, clinical study to evaluate efficacy of ayuartis capsules in patients suffering from osteoarthritis of the knee(s)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891992/
https://www.ncbi.nlm.nih.gov/pubmed/31831964
http://dx.doi.org/10.4103/ayu.AYU_8_18
work_keys_str_mv AT mundhenarendrab anopenlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT tamolisanjaymotilal anopenlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT pandeshishirpurushottam anopenlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT kulkarnisavitaambadas anopenlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT patilvishalg anopenlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT mahadikswapnalib anopenlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT mundhenarendrab openlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT tamolisanjaymotilal openlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT pandeshishirpurushottam openlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT kulkarnisavitaambadas openlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT patilvishalg openlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees
AT mahadikswapnalib openlabelprospectivemulticenterclinicalstudytoevaluateefficacyofayuartiscapsulesinpatientssufferingfromosteoarthritisoftheknees